• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤肿瘤部位促进人类肿瘤浸润淋巴细胞向 T17 谱系的分化。

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T17 lineage in humans.

机构信息

Department of Neurology, Technical University of Munich School of Medicine, 81675 Munich, Germany.

Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, 81675 Munich, Germany.

出版信息

Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2206208119. doi: 10.1073/pnas.2206208119. Epub 2022 Aug 15.

DOI:10.1073/pnas.2206208119
PMID:35969754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9407554/
Abstract

Although glioblastoma multiforme (GBM) is not an invariably cold tumor, checkpoint inhibition has largely failed in GBM. In order to investigate T cell-intrinsic properties that contribute to the resistance of GBM to endogenous or therapeutically enhanced adaptive immune responses, we sorted CD4 and CD8 T cells from the peripheral blood, normal-appearing brain tissue, and tumor bed of nine treatment-naive patients with GBM. Bulk RNA sequencing of highly pure T cell populations from these different compartments was used to obtain deep transcriptomes of tumor-infiltrating T cells (TILs). While the transcriptome of CD8 TILs suggested that they were partly locked in a dysfunctional state, CD4 TILs showed a robust commitment to the type 17 T helper cell (T17) lineage, which was corroborated by flow cytometry in four additional GBM cases. Therefore, our study illustrates that the brain tumor environment in GBM might instruct T17 commitment of infiltrating T helper cells. Whether these properties of CD4 TILs facilitate a tumor-promoting milieu and thus could be a target for adjuvant anti-T17 cell interventions needs to be further investigated.

摘要

尽管多形性胶质母细胞瘤(GBM)并非始终为冷肿瘤,但检查点抑制在 GBM 中基本上已经失败。为了研究导致 GBM 对内源性或治疗性增强的适应性免疫反应产生抵抗的 T 细胞内在特性,我们从 9 名未经治疗的 GBM 患者的外周血、正常外观的脑组织和肿瘤床中分离出 CD4 和 CD8 T 细胞。使用来自这些不同隔室的高纯度 T 细胞群体的批量 RNA 测序来获得浸润性 T 细胞(TIL)的深度转录组。虽然 CD8 TIL 的转录组表明它们部分处于功能失调状态,但 CD4 TIL 显示出对 17 型辅助性 T 细胞(T17)谱系的强烈承诺,这在另外 4 例 GBM 病例中的流式细胞术得到了证实。因此,我们的研究表明,GBM 中的脑肿瘤环境可能指示浸润性辅助性 T 细胞的 T17 承诺。这些 CD4 TIL 的特性是否促进了肿瘤促进环境,因此可能成为辅助性抗 T17 细胞干预的目标,需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/a6776559c08f/pnas.2206208119fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/594023a5378e/pnas.2206208119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/f5810acc451d/pnas.2206208119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/1db144cce0d2/pnas.2206208119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/6f59aab3033a/pnas.2206208119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/8687e37d4525/pnas.2206208119fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/a1017ee2d34a/pnas.2206208119fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/a6776559c08f/pnas.2206208119fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/594023a5378e/pnas.2206208119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/f5810acc451d/pnas.2206208119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/1db144cce0d2/pnas.2206208119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/6f59aab3033a/pnas.2206208119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/8687e37d4525/pnas.2206208119fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/a1017ee2d34a/pnas.2206208119fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5f/9407554/a6776559c08f/pnas.2206208119fig07.jpg

相似文献

1
The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T17 lineage in humans.胶质母细胞瘤肿瘤部位促进人类肿瘤浸润淋巴细胞向 T17 谱系的分化。
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2206208119. doi: 10.1073/pnas.2206208119. Epub 2022 Aug 15.
2
Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8 T Cells is Determined by Their Differentiation Status in Glioblastoma.免疫检查点抑制剂诱导的胶质母细胞瘤中浸润 CD8 T 细胞的再激活取决于其分化状态。
Clin Cancer Res. 2019 Apr 15;25(8):2549-2559. doi: 10.1158/1078-0432.CCR-18-2564. Epub 2019 Jan 18.
3
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.新发和复发性胶质母细胞瘤的免疫表型分析定义了外周和肿瘤浸润淋巴细胞中不同的免疫衰竭特征。
Clin Cancer Res. 2018 Sep 1;24(17):4187-4200. doi: 10.1158/1078-0432.CCR-17-2617. Epub 2018 Feb 14.
4
Tumor-infiltrating CD8 sub-populations in primary and recurrent glioblastoma: An study.原发性和复发性胶质母细胞瘤中的肿瘤浸润性CD8亚群:一项研究。
Heliyon. 2024 Mar 4;10(5):e27329. doi: 10.1016/j.heliyon.2024.e27329. eCollection 2024 Mar 15.
5
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.胶质母细胞瘤中性别、治疗策略、分子背景和肿瘤浸润淋巴细胞的预后影响:一个尚未解决的难题。
Genes (Basel). 2023 Feb 15;14(2):501. doi: 10.3390/genes14020501.
6
Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.健康供体和多形性胶质母细胞瘤患者中PD-1+和PD-1-CD4+效应T细胞的功能差异。
PLoS One. 2017 Sep 7;12(9):e0181538. doi: 10.1371/journal.pone.0181538. eCollection 2017.
7
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.胶质母细胞瘤患者肿瘤浸润淋巴细胞中FoxP3 +调节性T细胞比例增加与肿瘤复发及生存期缩短相关。
Cancer Immunol Immunother. 2015 Apr;64(4):419-27. doi: 10.1007/s00262-014-1651-7. Epub 2015 Jan 3.
8
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.T 细胞耗竭特征随肿瘤类型而变化,在神经胶质瘤中较为严重。
Clin Cancer Res. 2018 Sep 1;24(17):4175-4186. doi: 10.1158/1078-0432.CCR-17-1846. Epub 2018 Feb 7.
9
Immune involvement of the contralateral hemisphere in a glioblastoma mouse model.胶质母细胞瘤小鼠模型中对侧半球的免疫参与。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000323.
10
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population.胶质母细胞瘤浸润的 CD8+ T 细胞主要是克隆扩增的 GZMK+效应细胞群体。
Cancer Discov. 2024 Jun 3;14(6):1106-1131. doi: 10.1158/2159-8290.CD-23-0913.

引用本文的文献

1
The role of IL-17 in the pathogenesis and treatment of glioblastoma-an update on the state of the art and future perspectives.IL-17 在胶质母细胞瘤发病机制和治疗中的作用——最新研究进展及未来展望。
Med Oncol. 2024 Jun 25;41(8):187. doi: 10.1007/s12032-024-02434-1.
2
Non-Tumor Cells within the Tumor Microenvironment-The "Eminence Grise" of the Glioblastoma Pathogenesis and Potential Targets for Therapy.肿瘤微环境中的非肿瘤细胞——胶质母细胞瘤发病机制中的“幕后黑手”和潜在治疗靶点。
Cells. 2024 May 9;13(10):808. doi: 10.3390/cells13100808.
3
Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies.

本文引用的文献

1
Glial and myeloid heterogeneity in the brain tumour microenvironment.脑肿瘤微环境中的神经胶质细胞和髓样细胞异质性。
Nat Rev Cancer. 2021 Dec;21(12):786-802. doi: 10.1038/s41568-021-00397-3. Epub 2021 Sep 28.
2
Role of IL-6 in the commitment of T cell subsets.白细胞介素-6 在 T 细胞亚群分化中的作用。
Cytokine. 2021 Oct;146:155654. doi: 10.1016/j.cyto.2021.155654. Epub 2021 Jul 26.
3
UCell: Robust and scalable single-cell gene signature scoring.UCell:强大且可扩展的单细胞基因特征评分
胶质母细胞瘤免疫治疗的放射基因组学生物标志物:磁共振成像研究的系统评价
Neurooncol Adv. 2024 Apr 5;6(1):vdae055. doi: 10.1093/noajnl/vdae055. eCollection 2024 Jan-Dec.
4
Basic Science of Neuroinflammation and Involvement of the Inflammatory Response in Disorders of the Nervous System.神经炎症的基础科学及炎症反应在神经系统疾病中的作用。
Magn Reson Imaging Clin N Am. 2024 May;32(2):375-384. doi: 10.1016/j.mric.2024.01.003. Epub 2024 Feb 6.
5
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.胶质瘤:连接肿瘤微环境、患者免疫特征与新型个性化免疫疗法
Front Immunol. 2024 Jan 11;14:1299064. doi: 10.3389/fimmu.2023.1299064. eCollection 2023.
6
Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology.基于机器学习级联的拉曼组织病理学快速可视化胶质母细胞瘤免疫微环境中的 PD-L1 表达水平。
J Adv Res. 2024 Nov;65:257-271. doi: 10.1016/j.jare.2023.12.002. Epub 2023 Dec 10.
7
Editorial: Modern neurosurgical management of gliomas, including local therapies.社论:胶质瘤的现代神经外科治疗,包括局部治疗。
Front Oncol. 2023 Aug 8;13:1217180. doi: 10.3389/fonc.2023.1217180. eCollection 2023.
8
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.胶质母细胞瘤中性别、治疗策略、分子背景和肿瘤浸润淋巴细胞的预后影响:一个尚未解决的难题。
Genes (Basel). 2023 Feb 15;14(2):501. doi: 10.3390/genes14020501.
9
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis.光动力疗法杀伤的胶质瘤细胞负载的树突状细胞瘤苗诱导 Th17 型抗肿瘤免疫,并提供用于预测胶质瘤预后的 4 基因标志物。
Cell Death Dis. 2022 Dec 21;13(12):1062. doi: 10.1038/s41419-022-05514-0.
10
Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic.临床中的细胞癌症免疫疗法的开发与制造。
Clin Cancer Res. 2023 Mar 1;29(5):843-857. doi: 10.1158/1078-0432.CCR-22-2257.
Comput Struct Biotechnol J. 2021 Jun 30;19:3796-3798. doi: 10.1016/j.csbj.2021.06.043. eCollection 2021.
4
Type 17 immunity promotes the exhaustion of CD8 T cells in cancer.17 型免疫促进癌症中 CD8 T 细胞的耗竭。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002603.
5
A vaccine targeting mutant IDH1 in newly diagnosed glioma.针对新诊断的神经胶质瘤中突变 IDH1 的疫苗。
Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24.
6
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.阻断白介素-17A 可增强微卫星稳定型结直肠癌对 PD-1 免疫治疗的反应。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001895.
7
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy.在单细胞水平进行深入免疫表型分析,结合使用抗 IL-17 和检查点阻断药物,为基于数据指导的个性化免疫治疗的临床前模型提供了一种有效的治疗方法。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001358.
8
Immune and Clinical Features of Expression in Glioma by Analysis.通过分析胶质瘤中[具体基因或蛋白名称缺失]的表达的免疫和临床特征 。 (注:原文中by后面的内容缺失,导致翻译不够完整准确)
Front Bioeng Biotechnol. 2020 Jun 30;8:592. doi: 10.3389/fbioe.2020.00592. eCollection 2020.
9
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.人脑癌的单细胞图谱揭示了组织侵袭性白细胞的肿瘤特异性指令。
Cell. 2020 Jun 25;181(7):1626-1642.e20. doi: 10.1016/j.cell.2020.04.055. Epub 2020 May 28.
10
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.脑肿瘤微环境景观的剖析揭示了免疫细胞的疾病特异性改变。
Cell. 2020 Jun 25;181(7):1643-1660.e17. doi: 10.1016/j.cell.2020.05.007. Epub 2020 May 28.